The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor

Genes and Development

Volumn 17, Issue 15, 2003, Pages 1841-1854

  Fox, Casey J ^a,b   Hammerman, Peter S ^a,b   Cinalli, Ryan M ^a,b   Master, Stephen R ^a,b   Chodosh, Lewis A ^a,b   Thompson, Craig B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Akt; Kinase; Pim 2; TOR; Transcriptional regulation

Indexed keywords

PIM 2 PROTEIN KINASE; PROTEIN BAD; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL SIZE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC VECTORS; GLUCOSE; INTERLEUKIN-3; LACTATES; MEMBRANE POTENTIALS; MICE; MITOCHONDRIA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHORYLATION; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS; STAUROSPORINE; THAPSIGARGIN; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSGENES;

EUKARYOTA; TOR;

EID: 0042626302     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1105003     Document Type: Article

References (50)

1. Algate, P.A., Steelman, L.S., Mayo, M.W., Miyajima, A., and McCubrey, J.A. 1994. Regulation of the interleukin-3 (IL-3) receptor by IL-3 in the fetal liver-derived FL5.12 cell line. Blood 83: 2459-2468.
2. Allen, J.D. and A. Berns. 1996. Complementation tagging of cooperating oncogenes in knockout mice. Semin Cancer Biol 7: 299-306.
3. Allen, J.D., Verhoeven, E., Domen, J., van der Valk, M., and Berns, A. 1997. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15: 1133-1141.
4. Amson, R., Sigaux, F., Przedborski, S., Flandrin, G., Givol, D., and Telerman, A. 1989. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc. Natl. Acad. Sci. 86: 8857-8861.
5. Arden, K.C. and Biggs III, W.H. 2002. Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch. Biochem. Biophys. 403: 292-298.
6. Basso, A.D., Solit, D.B., Chiosis, G., Giri, B., Tsichlis, P., and Rosen, N. 2002. Akt forms an intracellular complex with Hsp90 and Cdc37 and is destabilized by inhibitors of Hsp90 function. J. Biol. Chem. 42: 39858-39866
7. Breuer, M.L., Cuypers, H.T., and Berns, A. 1989. Evidence for the involvement of pim-2, a new common proviral insertion site, in progression of lymphomas. EMBO J. 8: 743-781.
8. Claudio, J.O., Masih-Khan, E., Tang, H., Goncalves, J., Voralia, M., Li, Z.H., Nadeem, V., Cukerman, E., Francisco-Pabalan, O., Liew, C.C., et al. 2002. A molecular compendium of genes expressed in multiple myeloma. Blood 100: 2175-2186.
9. Clemens, M.J., Bushell, M., Jeffrey, I. W., Pain, V. M., and Morley, S.J. 2000. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 7: 603-615.
10. Cory, S. and Adams, J.M. 2002. The bcl2 family: Regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2: 647-656.
11. Covey, D.F., Han, M., Kumar, A.S., de La Cruz, M.A., Meadows, E.S., Hu, Y., Tonnies, A., Nathan, D., Coleman, M., Benz, A., et al. 2000. Neurosteroid analogues. 8. Structure-activity studies of N-acylated 17a-aza-D-homosteroid analogues of the anesthetic steroids (3α, 5α)- and (3α, 5β)-3-hydroxypregnan-20-one. J. Med. Chem. 43; 3201-3204.
12. D'Cruz, C.M., Moody, S.E., Master, S.R., Hartman, J.L., Keiper, E.A., Imielinski, M.B., Cox, J.D., Wang, J.Y., Ha, S.I., Keister, B.A., et al. 2002. Persistent parity-induced changes in growth factors, TGF-β3, and differentiation in the rodent mammary gland. Mol. Endocrinol. 16: 2034-2051.
13. Dhanasekaran, S.M., Barrette, T.R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K.J., Rubin, M.A., and Chinnaiyan, A.M. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
14. Edinger, A.L. and Thompson, C.B. 2002. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13: 2276-2288.
15. Feldman, J.D., Vician, L., Crispino, M., Tocco, G., Marcheselli, V.L., Bazan, N.G., Baudry, M., and Herschman, H.R. 1998. KID-1, a protein kinase induced by depolarization in brain. J. Biol. Chem. 273: 16535-16543.
16. Giza, C.C., Prins, M.L., Hovda, D.A., Herschman, H.R., and Feldman, J.D. 2002. Genes preferentially induced by depolarization after concussive brain injury: Effects of age and injury severity. J. Neurotrauma 19: 387-402.
17. Hoffman, B., Amanullah, A., Shafarenko, M., and Liebermann, D.A. 2002. The proto-oncogene c-myc in hematopoietic development and leukemogenesis. Oncogene 21: 3414-3421.
18. Huse, M. and Kuriyan, J. 2002. The conformational plasticity of protein kinases. Cell 109: 275-282.
19. Konietzko, U., Kauselmann, G., Scafidi, J., Staubli, U., Mikkers, H., Bems, A., Schweizer, M., Waltereit, R., and Kuhl, D. 1999. Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP. EMBO J. 18: 3359-3369.
20. Leverson, J.D., Koskinen, P.J., Orrico, F.C., Rainio, E.M., Jalkanen, K.J., Dash, A.B., Eisenman, R.N., and Ness, S.A. 1998. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell 2: 417-425.
21. 2+ homeostasis by altering expression of inositol 1,4,5-trisphosphate receptors. Proc. Natl. Acad. Sci. 99: 9830-9835.
22. Li, J., Peet, G.W., Balzarano, D., Li, X., Massa, P., Barton, R.W., and Marcu, K.B. 2001. Novel NEMO/IkappaB kinase and NF-kappa B target genes at the pre-B to immature B cell transition. J. Biol. Chem. 276: 18579-18590.
23. Li, S., Sonenberg, N., Gingras, A.C., Peterson, M., Avdulov, S., Polunovsky, V.A., and Bitterman, P.B. 2002. Translational control of cell fate: Availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency. Mol. Cell. Biol. 22: 2853-2861.
24. Lilly, M., Sandholm, J., Cooper, J.J., Koskinen, P.J., and Kraft, A. 1999. The Pim-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 18: 4022-4031.
25. Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J.L., Bonenfant, D., Oppliger, W., Jenoe, P., and Hall, M.N. 2002. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10: 457-468.
26. Mazel, S., Burtrum, D., and Petrie, H.T. 1996. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183: 2219-2226.
27. Mikkers, H., Allen, J., Knipscheer, P., Romeyn, L., Hart, A., Vink, E., and Berns, A. 2002. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat. Genet. 32: 153-159.
28. Mikovits, J., Ruscetti, F., Zhu, W., Bagni, R., Dorjsuren, D., and Shoemaker, R. 2001. Potential cellular signatures of viral infections in human hematopoietic cells. Dis Markers 17: 173-178.
29. Mochizuki, T., Kitanaka, C., Noguchi, K., Muramatsu, T., Asai, A., and Kuchino, Y. 1999. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274: 18659-18666.
30. Moroy, T., Verbeek, S., Ma, A., Achacoso, P., Berns, A., and Alt, F. 1991. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice. Oncogene 6: 1941-1948.
31. Muschen, M., Lee, S., Zhou, G., Feldhahn, N., Barath, V.S., Chen, J., Moers, C., Kronke, M., Rowley, J.D., and Wang, S.M. 2002. Molecular portraits of B cell lineage commitment. Proc. Natl. Acad. Sci. 99: 10014-1009.
32. Neill, G.W. and Kelsell, D.P. 2001. Spotting prostate cancer. Trends Mol. Med. 7: 432.
33. Nicholson, K.M. and Anderson, N.G. 2002. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 14: 381-395.
34. Omura, S., Sasaki, Y., Iwai, Y., and Takeshima, H. 1995. Staurosporine, a potentially important gift from a microorganism. J. Antibiot. (Tokyo) 48: 535-548.
35. O'Reilly, L.A., Huang, D.C., and Strasser, A. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15: 6979-6990.
36. Pelengaris, S., Khan, M., and Evan, G. 2002. c-myc: More than just a matter of life and death. Nat. Rev. Cancer 2: 764-776.
37. Pircher, T.I., Zhao, S., Geiger, J.N., Joneja, B., and Wojchowski, D.M. 2000. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death. Oncogene 19: 3684-3692.
38. L promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276: 12041-12048.
39. Rathmell, J.C., Vander Heiden, M.G., Harris, M.H., Frauwirth, K.A., and Thompson, C.B. 2000. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6: 683-692.
40. Schulte, T.W., Akinaga, S., Murakata, T., Agatsuma, T., Sugimoto, S., Nakano, H., Lee, Y.S., Simen, B.B., Argon, Y., Felts, S., et al. 1999. Interaction of radicicol with members of the heat shock protein 90 family of molecular chaperones. Mol. Endocrinol. 13: 1435-1448.
41. Selten, G., Cuypers, H.T., and Berns, A. 1985. Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J. 4: 1793-1798.
42. Temple, R., Allen, E., Fordham, J., Phipps, S., Schneider, H.C., Lindauer, K., Hayes, I., Lockey, J., Pollock, K., and Jupp, R. 2001. Microarray analysis of eosinophils reveals a number of candidate survival and apoptosis genes. Am. J. Respir. Cell. Mol Biol. 25: 425-433.
43. 2+-ATPases. Trends Pharmacol. Sci. 19: 131-135.
44. Tulchinsky, E. 2000. Fos family members: Regulation, structure and role in oncogenic transformation. Histol. Histopathol. 15: 921-928.
45. van der Lugt, N.M., Domen, J., Verhoeven, E., Linders, K., van der Gulden, H., Allen, I., and Berns, A. 1995. Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2. EMBO J. 14: 2536-2544.
46. Verbeek, S., van Lohuizen, M., van der Valk, M., Domen, J., Kraal, G., and Berns, A. 1991. Mice bearing the E μ-myc and E μ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol. Cell. Biol. 11: 1176-1179.
47. Vlahos, C.I., Matter, W.F., Hui, K.Y., and Brown, R.F. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269: 5241-5248.
48. Wang, Z., Bhattacharya, N., Meyer, M.K., Seimiya, H., Tsuruo, T., Tonani, J.A., and Magnuson, N.S. 2001. Pim-1 negatively regulates the activity of PTP-U2S phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch. Biochem. Biophys 390: 9-18.
49. Xu, L.G., Wu, M., Hu, J., Zhai, Z., and Shu, H.B. 2002. Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol. 72: 410-416.
50. Yoshida, S., Kaneita, Y., Aoki, Y., Seto, M., Mori, S., and Moriyama, M. 1999. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5′-RACE and LA-PCR analyses of biopsy samples. Oncogene 18: 7994-7999.